Results 151 to 160 of about 1,040,359 (356)
High‐Pressure Biotechnology in Medicine and Pharmaceutical Science [PDF]
, 2001 Patrick Masson +2 more
openalex +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Recurrent high‐grade gliomas have a poor prognosis and limited therapeutic options. This study aimed to evaluate the safety and efficacy of SYHA1813, a dual inhibitor of VEGFR and CSF1R, in patients with recurrent high‐grade gliomas.
Zhuang Kang +16 more
wiley +1 more source
New strategies for polymer development in pharmaceutical science — a short review [PDF]
, 2001 Antony Godwin +6 more
openalex +1 more source
Durability of Response to B‐Cell Maturation Antigen‐Directed mRNA Cell Therapy in Myasthenia Gravis
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective We report the 12‐month follow‐up outcomes from a Phase 2 clinical trial (NCT04146051) evaluating Descartes‐08, a BCMA‐directed RNA chimeric antigen receptor T‐cell (rCAR‐T) therapy for refractory generalized myasthenia gravis (MG).
Nizar Chahin +10 more
wiley +1 more source
Doctors’ interactions with the pharmaceutical industry: science or commerce? [PDF]
, 2001 Paul A. Komesaroff
openalex +1 more source
Old School Catalog 1921-22, The School of Pharmacy [PDF]
, 1921 https://scholar.valpo.edu/oldschoolcatalogs/1089/thumbnail ...
Valparaiso University
core +2 more sources
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To quantify the number and volume of whole brain perivascular spaces (PVS) using a detection and segmentation algorithm in participants with multiple sclerosis (MS) and patients with disorders mimicking MS known to potentially influence PVS, such as cerebrovascular disease.
Elle M. Levit +5 more
wiley +1 more source